8,224 Shares in HealthEquity, Inc. (NASDAQ:HQY) Bought by Peterson Wealth Services

Peterson Wealth Services purchased a new stake in HealthEquity, Inc. (NASDAQ:HQY) during the 1st quarter, Holdings Channel.com reports. The fund purchased 8,224 shares of the company’s stock, valued at approximately $671,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Vanguard Group Inc. increased its holdings in HealthEquity by 1.2% in the 4th quarter. Vanguard Group Inc. now owns 8,619,499 shares of the company’s stock valued at $571,473,000 after buying an additional 104,084 shares during the period. Wasatch Advisors LP boosted its stake in shares of HealthEquity by 8.3% in the 1st quarter. Wasatch Advisors LP now owns 7,409,080 shares of the company’s stock valued at $604,803,000 after purchasing an additional 569,249 shares in the last quarter. Clearbridge Investments LLC boosted its stake in shares of HealthEquity by 6.9% in the 4th quarter. Clearbridge Investments LLC now owns 2,357,572 shares of the company’s stock valued at $156,307,000 after purchasing an additional 152,897 shares in the last quarter. Mackenzie Financial Corp boosted its stake in shares of HealthEquity by 58.2% in the 4th quarter. Mackenzie Financial Corp now owns 1,807,407 shares of the company’s stock valued at $119,831,000 after purchasing an additional 664,979 shares in the last quarter. Finally, Franklin Resources Inc. boosted its stake in shares of HealthEquity by 7.0% in the 4th quarter. Franklin Resources Inc. now owns 1,480,655 shares of the company’s stock valued at $98,167,000 after purchasing an additional 96,583 shares in the last quarter. Institutional investors own 99.55% of the company’s stock.

Insider Buying and Selling

In related news, CEO Jon Kessler sold 32,326 shares of the stock in a transaction that occurred on Monday, June 24th. The stock was sold at an average price of $82.83, for a total transaction of $2,677,562.58. Following the completion of the sale, the chief executive officer now directly owns 232,176 shares of the company’s stock, valued at approximately $19,231,138.08. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. In other HealthEquity news, CEO Jon Kessler sold 32,326 shares of the company’s stock in a transaction that occurred on Monday, June 24th. The stock was sold at an average price of $82.83, for a total transaction of $2,677,562.58. Following the completion of the transaction, the chief executive officer now owns 232,176 shares of the company’s stock, valued at approximately $19,231,138.08. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Vice Chairman Stephen Neeleman sold 2,080 shares of the company’s stock in a transaction that occurred on Friday, June 7th. The stock was sold at an average price of $85.01, for a total value of $176,820.80. Following the transaction, the insider now directly owns 90,515 shares of the company’s stock, valued at approximately $7,694,680.15. The disclosure for this sale can be found here. In the last three months, insiders sold 34,806 shares of company stock valued at $2,888,383. 2.20% of the stock is owned by corporate insiders.

HealthEquity Trading Down 1.2 %

Shares of HQY stock traded down $0.99 on Friday, reaching $82.57. The company had a trading volume of 471,188 shares, compared to its average volume of 536,155. The company has a current ratio of 4.39, a quick ratio of 4.39 and a debt-to-equity ratio of 0.44. The stock has a market cap of $7.18 billion, a PE ratio of 89.75, a PEG ratio of 1.41 and a beta of 0.57. The company has a 50-day moving average of $81.48 and a 200-day moving average of $78.69. HealthEquity, Inc. has a 12 month low of $61.32 and a 12 month high of $88.26.

HealthEquity (NASDAQ:HQY) last posted its earnings results on Monday, June 3rd. The company reported $0.55 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.47 by $0.08. HealthEquity had a return on equity of 7.77% and a net margin of 7.71%. The business had revenue of $287.60 million during the quarter, compared to analysts’ expectations of $278.78 million. On average, equities analysts forecast that HealthEquity, Inc. will post 2.12 earnings per share for the current year.

Wall Street Analysts Forecast Growth

HQY has been the topic of several recent analyst reports. Robert W. Baird boosted their target price on shares of HealthEquity from $98.00 to $104.00 and gave the company an “outperform” rating in a research note on Tuesday, June 4th. BTIG Research boosted their target price on shares of HealthEquity from $100.00 to $110.00 and gave the company a “buy” rating in a research note on Wednesday, March 20th. Royal Bank of Canada restated an “outperform” rating and issued a $92.00 target price on shares of HealthEquity in a research note on Tuesday, June 4th. JMP Securities upped their price target on shares of HealthEquity from $101.00 to $105.00 and gave the stock a “market outperform” rating in a research report on Tuesday, June 4th. Finally, Wells Fargo & Company upped their price target on shares of HealthEquity from $107.00 to $110.00 and gave the stock an “overweight” rating in a research report on Thursday, June 20th. One investment analyst has rated the stock with a hold rating and twelve have given a buy rating to the company. According to MarketBeat.com, HealthEquity currently has a consensus rating of “Moderate Buy” and an average target price of $101.67.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.